Prothena Gives Amyloidosis Drug Birtamimab A Second Chance

 
• By Joseph Haas
  
new growth in tree trunk
Prothena found a new way forward for birtamimab with a deep dive into Phase III VITAL

More from Clinical Trials

More from R&D